EE517 Cost-Effectiveness Analysis of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Greece
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.782
https://www.valueinhealthjournal.com/article/S1098-3015(23)03912-8/fulltext
Title :
EE517 Cost-Effectiveness Analysis of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03912-8&doi=10.1016/j.jval.2023.09.782
First page :
Section Title :
Open access? :
No
Section Order :
10269